These findings indicate that PI3K-Akt, NF-κB, and NRF2 signaling pathways may form an intricate regulatory network that shapes the post-stroke immune microenvironment, thus highlighting their potential as targets for therapeutic immunomodulation. The gene discussed is NFKB1; the disease is Stroke.